Tetrahydronaphthyridine derivatives useful as histamine H3 receptor ligands

Details for Australian Patent Application No. 2005243403 (hide)

Owner Pfizer Inc.

Inventors Strang, Ross Sinclair; Lunn, Graham; Mathias, John Paul

Agent Allens Arthur Robinson

Pub. Number AU-B-2005243403

PCT Pub. Number WO2005/111036

Priority 04291222.0 12.05.04 EP

Filing date 6 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 7 October 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111036 Priority application(s): WO2005/111036

7 October 2010 Application Accepted

  Published as AU-B-2005243403

3 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243406-Process and device for building a tunnel immersed on a sub-sea soil

2005243401-Suspension plate for fixing to ceiling